Amplitude Vascular Systems
Ann Arbor, US · Founded 2019 · 3 known investors
Find your way into Amplitude Vascular Systems
Sign up to see every warm intro you have to Amplitude Vascular Systems
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amplitude Vascular Systems team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
Founders & leadership
Amplitude Vascular Systems was founded in 2019 by Robert Chisena, Ph.D..



Board

Investors · 3
How we know: BioStar Capital's portfolio page · the company's own site · board seat on SEC Form D · funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements$29.3M disclosed across 3 of 5 rounds · 2020–2025
▶$23.6MraisedOct 2024 · 4 investors · Other Health CareRule 506(b)
- Hitinder GurmDirector
- Robert ChisenaExecutive Officer
- Jason RichardsonDirector
- Louis CannonDirector
- Andrew CaseyExecutive Officer
- Sean GilliganExecutive Officer
- William H. KuchemanDirector
- Mark TolandExecutive Officer, Director
- Offering amount
- $36M
- Amount sold
- $23.6M
- Minimum investment
- $10K
- First sale
- Oct 2024
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$4.4MraisedOct 2022 · 3 investors · Other Health CareRule 506(b)
- Mark TolandExecutive Officer, Director
- Louis CannonDirector
- David LongDirector
- Hitinder GurmDirector
- Hank KuchemanDirector
- Robert ChisenaExecutive Officer
- Offering amount
- $22.4M
- Amount sold
- $4.4M
- Minimum investment
- $10K
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$1.2MraisedJul 2020 · 4 investors · BiotechnologyRule 506(b)
- David LongDirector
- Mark TolandExecutive Officer, Director
- Hitinder GurmExecutive Officer, Director
- Robert ChisenaExecutive Officer, Director
- Louis CannonDirector
- Offering amount
- $1.5M
- Amount sold
- $1.2M
- Minimum investment
- $10K
- Proceeds to insiders
- $470K
- First sale
- Jun 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Amplitude Vascular Systems do?
- AVS develops the Pulse IVL system, a medical device for treating calcified arterial disease using a unique mechanism of action for improved deliverability in peripheral and coronary applications.
- Who founded Amplitude Vascular Systems?
- Amplitude Vascular Systems was founded by Robert Chisena, Ph.D. in 2019.
- Who are Amplitude Vascular Systems's investors?
- Amplitude Vascular Systems's investors include BioStar Capital, Corewell Health Ventures, ID Ventures.
- How much funding has Amplitude Vascular Systems raised?
- Amplitude Vascular Systems has disclosed $29.3M raised across 3 of its 5 known rounds.
- Where is Amplitude Vascular Systems headquartered?
- Amplitude Vascular Systems is headquartered in Ann Arbor, US.

